Cargando…

Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis

Detalles Bibliográficos
Autores principales:	Lo, Martin W., Lee, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224118/ https://www.ncbi.nlm.nih.gov/pubmed/33269780 http://dx.doi.org/10.4103/1673-5374.300441

Ejemplares similares

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

Fibrosis as a common trait in amyotrophic lateral sclerosis tissues
por: Apolloni, Savina, et al.
Publicado: (2021)

Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)

Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?
por: Carreras, Francisco Javier
Publicado: (2016)

Mending the broken in amyotrophic lateral sclerosis: DNA damage and repair in motor neuron degeneration
por: Kim, Byung Woo, et al.
Publicado: (2020)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?
por: Allen, Scott P.
Publicado: (2020)

Complement activation at the motor end-plates in amyotrophic lateral sclerosis
por: Bahia El Idrissi, Nawal, et al.
Publicado: (2016)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis
por: Kanekura, Kohsuke, et al.
Publicado: (2022)

Muscle secretion of toxic factors, regulated by miR126-5p, facilitates motor neuron degeneration in amyotrophic lateral sclerosis
por: Maimon, Roy, et al.
Publicado: (2019)

Combination of novel RNA sequencing and sophisticated network modeling to reveal a common denominator in amyotrophic lateral sclerosis?
por: Dash, Banaja P., et al.
Publicado: (2023)

Redox Regulation in Amyotrophic Lateral Sclerosis
por: Parakh, Sonam, et al.
Publicado: (2013)

Immunometabolism and inflammation: a perspective on animal productivity
por: Davis, Ellen
Publicado: (2022)

Fused in sarcoma-amyotrophic lateral sclerosis as a novel member of DNA single strand break diseases with pure neurological phenotypes
por: Naumann, Marcel, et al.
Publicado: (2020)

Neuromuscular junction mitochondrial enrichment: a “double-edged sword” underlying the selective motor neuron vulnerability in amyotrophic lateral sclerosis
por: Altman, Topaz, et al.
Publicado: (2020)

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
por: Cuyàs, Elisabet, et al.
Publicado: (2020)

Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application
por: Walker, Chandler L.
Publicado: (2019)

Diffusion tensor imaging as a tool to detect presymptomatic axonal degeneration in a preclinical spinal cord model of amyotrophic lateral sclerosis
por: Gatto, Rodolfo Gabriel
Publicado: (2018)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study
por: Kjældgaard, Anne-Lene, et al.
Publicado: (2021)

Immunometabolic considerations with regard to the domestic chicken, Gallus gallus
por: Elsasser, Ted H
Publicado: (2022)

Targeting immunometabolic pathways for combination therapy in Alzheimer's disease
por: Erichsen, Jennifer, et al.
Publicado: (2023)

Current status and future directions of amyotrophic lateral sclerosis research in Africa: a perspective
por: Aderinto, Nicholas, et al.
Publicado: (2023)

Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
por: Stubbs, Brianna J., et al.
Publicado: (2020)

The Peripheral Immune System and Amyotrophic Lateral Sclerosis
por: McCombe, Pamela A., et al.
Publicado: (2020)

What causes amyotrophic lateral sclerosis?
por: Martin, Sarah, et al.
Publicado: (2017)

Dysregulation of the complement cascade in the hSOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis
por: Lee, John D, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1d3agtvr0j2do509nta63v8daj